# Allogeneic Hematopoietic Stem Cell Transplantation for 4/M Neuroblastoma

> **NCT05303727** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University** · enrollment: 64 (estimated)

## Conditions studied

- Neuroblastoma

## Interventions

- **DRUG:** Anti Thymocyte Globulin
- **DRUG:** Fludarabine
- **DRUG:** Cyclophosphamide injection
- **DRUG:** Topotecan
- **DRUG:** Melphalan
- **DRUG:** Thiotepa
- **DRUG:** Busulfan
- **DRUG:** Cyclosporine
- **DRUG:** Tacrolimus
- **DRUG:** Mycophenolate Mofetil
- **DRUG:** Methotrexate

## Key facts

- **NCT ID:** NCT05303727
- **Lead sponsor:** Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2022-08
- **Primary completion:** 2027-08
- **Final completion:** 2027-08
- **Target enrollment:** 64 (ESTIMATED)
- **Last updated:** 2022-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05303727

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05303727, "Allogeneic Hematopoietic Stem Cell Transplantation for 4/M Neuroblastoma". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05303727. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*